Vaddi Krishna 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 5:20 pm Purchase | 2025-03-31 | 13G | Prelude Therapeutics Incorporated PRLD | Vaddi Krishna | 6,397,839 13.800% | 908,709 (+16.55%) | Filing |
| 2025-02-14 4:19 pm Purchase | 2024-12-31 | 13G | Prelude Therapeutics Incorporated PRLD | Vaddi Krishna | 5,489,130 9.500% | 581,044 (+11.84%) | Filing |
| 2024-02-12 4:26 pm Purchase | 2023-12-31 | 13G | Prelude Therapeutics Incorporated PRLD | Vaddi Krishna | 4,908,086 11.100% | 608,763 (+14.16%) | Filing |
| 2023-02-10 08:00 am Purchase | 2022-12-31 | 13G | Prelude Therapeutics Incorporated PRLD | Vaddi Krishna | 4,299,323 11.300% | 680,770 (+18.81%) | Filing |
| 2022-02-04 4:05 pm Purchase | 2021-12-31 | 13G | Prelude Therapeutics Incorporated PRLD | Vaddi Krishna | 3,618,553 9.700% | 680,781 (+23.17%) | Filing |
| 2021-02-11 4:06 pm Purchase | 2020-12-31 | 13G | Prelude Therapeutics Incorporated PRLD | Vaddi Krishna | 2,937,772 12.620% | 2,937,772 (New Position) | Filing |